Clinical Trials Directory

Trials / Terminated

TerminatedNCT02769806

Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma

Status
Terminated
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years – 82 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this project is to Compare new msCS and standard DSC-PWI methods in GBM patients undergoing post-operative MRI for monitoring of tumor progression.

Detailed description

Investigators will compare the novel to the standard DSC-PWI methods in twenty five GBM patients to determine whether novel method improves image quality in tumor regions. We will also compare accuracy of pseudoprogression (PsP) vs. early progressive disease (ePD) determinations by the two techniques. If successful, the project will culminate in a novel imaging method sequence optimized to monitor progression and guide treatment decisions in post-operative GBM patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREMRI

Timeline

Start date
2016-05-23
Primary completion
2019-06-21
Completion
2019-06-21
First posted
2016-05-12
Last updated
2023-01-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02769806. Inclusion in this directory is not an endorsement.

Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma (NCT02769806) · Clinical Trials Directory